Loading...
Asymmetric Dimethylarginine and Mortality in Stages 3 to 4 Chronic Kidney Disease
Background and objectives: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, reduces bioavailability of nitric oxide and induces endothelial dysfunction. This dimethylated amino acid accumulates in chronic kidney disease and may be involved in the pathophysiology...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Nephrology
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2689879/ https://ncbi.nlm.nih.gov/pubmed/19389824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.06671208 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|